Nontoxic diphtheria toxin derivates CRM197 and B-fragment can serve as the means for targeted curcumin delivery into sensitive cancer cells
Authors:
- 17 April 2024
- journal article
- review article
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 96
Abstract
No abstract availableKeywords
Funding Information
- National Academy of Sciences of Ukraine
This publication has 50 references indexed in Scilit:
- Curcumin: An epigenetic regulator and its application in cancerBiomedicine & Pharmacotherapy, 2022
- The geometry of diphtheria toxoid CRM197 channel assessed by thiazolium salts and nonelectrolytesBiophysical Journal, 2021
- Curcumin promotes cancer-associated fibroblasts apoptosis via ROS-mediated endoplasmic reticulum stressArchives of Biochemistry and Biophysics, 2020
- Curcumin induced apoptosis is mediated through oxidative stress in mutated p53 and wild type p53 colon adenocarcinoma cell linesJournal of Biochemical and Molecular Toxicology, 2020
- Inhibition of skin tumor promotion by TPA using a combination of topically applied ursolic acid and curcuminMolecular Carcinogenesis, 2018
- Therapeutic use of curcumin‐encapsulated and curcumin‐primed exosomesJournal of Cellular Physiology, 2018
- Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: Use as a conjugation protein in vaccines and other potential clinical applicationsBiologicals, 2011
- Synergistic anti‐tumor effect of paclitaxel with CRM197, an inhibitor of HB‐EGF, in ovarian cancerInternational Journal of Cancer, 2008
- Curcumin induces cell‐arrest and apoptosis in association with the inhibition of constitutively active NF‐κB and STAT3 pathways in Hodgkin's lymphoma cellsInternational Journal of Cancer, 2008
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983